Is Vir Biotechnology, Inc. (VIR) a Buy, Sell, or Hold?
Vir Biotechnology, Inc.
NASDAQ:VIR
$9.49 USD
-$0.23 (-2.37%)
- Volume
- 1.68M
- Average Volume
- 1.89M
- Market Capitalization
- $1.6B
- P/E Ratio
- -3.03
- Dividend Yield
- 0.00%
- Price Target
- $20.00
- Year High
- $11.66
- Year Low
- $4.16
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $7.11
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
28
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
60
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 3.69M
VIR Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
VIR Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Coughlin Timothy | director | 2026-06-09 | A-Award | 0 | 2026-06-10 |
| Coughlin Timothy | director | 2026-06-09 | A-Award | 8.51 | 2026-06-10 |
| Coughlin Timothy | director | 2026-06-09 | A-Award | 0 | 2026-06-10 |
| Coughlin Timothy | director | 2026-06-09 | 0 | 2026-06-10 | |
| Napolitano Janet | director | 2026-06-01 | S-Sale | 9.45 | 2026-06-02 |
| Sabatini Brent | officer: SVP, Chief Accounting Officer | 2026-06-01 | S-Sale | 9.45 | 2026-06-02 |
| Sigal Charles Elliott | director | 2026-05-27 | A-Award | 0 | 2026-05-28 |
| Sigal Charles Elliott | director | 2026-05-27 | A-Award | 9.1 | 2026-05-28 |
| Napolitano Janet | director | 2026-05-27 | A-Award | 0 | 2026-05-28 |
| Napolitano Janet | director | 2026-05-27 | A-Award | 9.1 | 2026-05-28 |
| MORE ROBERT J | director | 2026-05-27 | A-Award | 0 | 2026-05-28 |
| MORE ROBERT J | director | 2026-05-27 | A-Award | 9.1 | 2026-05-28 |
| Hatfield Jeffrey S. | director | 2026-05-27 | A-Award | 0 | 2026-05-28 |
| Hatfield Jeffrey S. | director | 2026-05-27 | A-Award | 9.1 | 2026-05-28 |
| Farid Ramy | director | 2026-05-27 | A-Award | 0 | 2026-05-28 |
| Farid Ramy | director | 2026-05-27 | A-Award | 9.1 | 2026-05-28 |
| BISCHOFBERGER NORBERT W | director | 2026-05-27 | A-Award | 0 | 2026-05-28 |
| BISCHOFBERGER NORBERT W | director | 2026-05-27 | A-Award | 9.1 | 2026-05-28 |
| SATO VICKI L | director | 2026-05-01 | S-Sale | 10.0466 | 2026-05-04 |
| De Backer Marianne | director, officer: President and CEO | 2026-04-29 | J-Other | 0 | 2026-04-30 |
| De Backer Marianne | director, officer: President and CEO | 2026-04-29 | J-Other | 0 | 2026-04-30 |
| De Backer Marianne | director, officer: President and CEO | 2026-04-06 | S-Sale | 9.156 | 2026-04-07 |
| SATO VICKI L | director | 2026-04-01 | S-Sale | 9.0735 | 2026-04-02 |
| Sabatini Brent | officer: SVP, Chief Accounting Officer | 2026-03-23 | S-Sale | 9.12 | 2026-03-24 |
| O'Byrne Jason | officer: EVP & Chief Financial Officer | 2026-03-20 | J-Other | 0 | 2026-03-23 |
| O'Byrne Jason | officer: EVP & Chief Financial Officer | 2026-03-20 | J-Other | 0 | 2026-03-23 |
| SATO VICKI L | director | 2026-03-02 | S-Sale | 9.5039 | 2026-03-03 |
| SATO VICKI L | director | 2026-03-02 | S-Sale | 9.98 | 2026-03-03 |
| SATO VICKI L | director | 2026-02-24 | M-Exempt | 1.485 | 2026-02-26 |
| SATO VICKI L | director | 2026-02-24 | S-Sale | 9.7521 | 2026-02-26 |
| SATO VICKI L | director | 2026-02-24 | S-Sale | 10.26 | 2026-02-26 |
| SATO VICKI L | director | 2026-02-24 | M-Exempt | 1.485 | 2026-02-26 |
| Sabatini Brent | officer: SVP, Chief Accounting Officer | 2026-02-24 | S-Sale | 9.5326 | 2026-02-26 |
| O'Byrne Jason | officer: EVP & Chief Financial Officer | 2026-02-24 | S-Sale | 9.5326 | 2026-02-26 |
| Eisner Mark | officer: EVP and Chief Medical Officer | 2026-02-24 | S-Sale | 9.5326 | 2026-02-26 |
| Eisner Mark | officer: EVP and Chief Medical Officer | 2026-02-25 | S-Sale | 9.82 | 2026-02-26 |
| de Verneuil Vanina | officer: EVP, General Counsel, Corp Sec | 2026-02-24 | S-Sale | 9.5326 | 2026-02-26 |
| de Verneuil Vanina | officer: EVP, General Counsel, Corp Sec | 2026-02-25 | S-Sale | 9.82 | 2026-02-26 |
| De Backer Marianne | director, officer: Chief Executive Officer | 2026-02-24 | S-Sale | 9.5326 | 2026-02-26 |
| Sabatini Brent | officer: SVP, Chief Accounting Officer | 2026-02-22 | A-Award | 0 | 2026-02-24 |
| Sabatini Brent | officer: SVP, Chief Accounting Officer | 2026-02-23 | S-Sale | 7.4528 | 2026-02-24 |
| Sabatini Brent | officer: SVP, Chief Accounting Officer | 2026-02-22 | A-Award | 7.56 | 2026-02-24 |
| O'Byrne Jason | officer: EVP & Chief Financial Officer | 2026-02-22 | A-Award | 0 | 2026-02-24 |
| O'Byrne Jason | officer: EVP & Chief Financial Officer | 2026-02-23 | S-Sale | 7.4528 | 2026-02-24 |
| O'Byrne Jason | officer: EVP & Chief Financial Officer | 2026-02-22 | A-Award | 7.56 | 2026-02-24 |
| Eisner Mark | officer: EVP and Chief Medical Officer | 2026-02-22 | A-Award | 0 | 2026-02-24 |
| Eisner Mark | officer: EVP and Chief Medical Officer | 2026-02-23 | S-Sale | 7.4528 | 2026-02-24 |
| Eisner Mark | officer: EVP and Chief Medical Officer | 2026-02-22 | A-Award | 7.56 | 2026-02-24 |
| de Verneuil Vanina | officer: EVP, General Counsel, Corp Sec | 2026-02-22 | A-Award | 0 | 2026-02-24 |
| de Verneuil Vanina | officer: EVP, General Counsel, Corp Sec | 2026-02-23 | S-Sale | 7.4528 | 2026-02-24 |
| de Verneuil Vanina | officer: EVP, General Counsel, Corp Sec | 2026-02-22 | A-Award | 7.56 | 2026-02-24 |
| De Backer Marianne | director, officer: Chief Executive Officer | 2026-02-22 | A-Award | 0 | 2026-02-24 |
| De Backer Marianne | director, officer: Chief Executive Officer | 2026-02-23 | S-Sale | 7.4528 | 2026-02-24 |
| De Backer Marianne | director, officer: Chief Executive Officer | 2026-02-22 | A-Award | 7.56 | 2026-02-24 |
| Sabatini Brent | officer: SVP, Chief Accounting Officer | 2026-02-13 | S-Sale | 7.79 | 2026-02-18 |
| SATO VICKI L | director | 2026-02-02 | S-Sale | 7.7123 | 2026-02-03 |
| SATO VICKI L | director | 2026-01-02 | S-Sale | 5.9265 | 2026-01-05 |
| SVF Endurance (Cayman) Ltd | 10 percent owner | 2025-12-01 | S-Sale | 5.9826 | 2025-12-03 |
| SATO VICKI L | director | 2025-12-01 | S-Sale | 6.0032 | 2025-12-02 |
| SVF Endurance (Cayman) Ltd | 10 percent owner | 2025-11-26 | S-Sale | 6.391 | 2025-12-01 |
| SVF Endurance (Cayman) Ltd | 10 percent owner | 2025-11-28 | S-Sale | 6.44 | 2025-12-01 |
| SVF Endurance (Cayman) Ltd | 10 percent owner | 2025-11-24 | S-Sale | 6.1491 | 2025-11-26 |
| SVF Endurance (Cayman) Ltd | 10 percent owner | 2025-11-25 | S-Sale | 6.38 | 2025-11-26 |
| O'Byrne Jason | officer: EVP & Chief Financial Officer | 2025-11-17 | S-Sale | 5.557 | 2025-11-18 |
| de Verneuil Vanina | officer: EVP, General Counsel, Corp Sec | 2025-11-05 | S-Sale | 5.16 | 2025-11-07 |
| de Verneuil Vanina | officer: EVP and General Counsel | 2025-11-03 | S-Sale | 5.863 | 2025-11-04 |
| SATO VICKI L | director | 2025-11-03 | S-Sale | 5.6385 | 2025-11-04 |
| SVF Endurance (Cayman) Ltd | 10 percent owner | 2025-10-28 | S-Sale | 6.5025 | 2025-10-30 |
| SVF Endurance (Cayman) Ltd | 10 percent owner | 2025-10-29 | S-Sale | 6.49 | 2025-10-30 |
| SVF Endurance (Cayman) Ltd | 10 percent owner | 2025-10-24 | S-Sale | 5.9595 | 2025-10-28 |
| SVF Endurance (Cayman) Ltd | 10 percent owner | 2025-10-27 | S-Sale | 6.0477 | 2025-10-28 |
| SVF Endurance (Cayman) Ltd | 10 percent owner | 2025-10-22 | S-Sale | 6.1529 | 2025-10-24 |
| SVF Endurance (Cayman) Ltd | 10 percent owner | 2025-10-23 | S-Sale | 5.9898 | 2025-10-24 |
| SVF Endurance (Cayman) Ltd | 10 percent owner | 2025-10-20 | S-Sale | 6.1998 | 2025-10-22 |
| SVF Endurance (Cayman) Ltd | 10 percent owner | 2025-10-21 | S-Sale | 6.3002 | 2025-10-22 |
| SVF Endurance (Cayman) Ltd | 10 percent owner | 2025-10-15 | S-Sale | 6.0702 | 2025-10-17 |
| SVF Endurance (Cayman) Ltd | 10 percent owner | 2025-10-16 | S-Sale | 6.1014 | 2025-10-17 |
| SVF Endurance (Cayman) Ltd | 10 percent owner | 2025-10-09 | S-Sale | 6.1428 | 2025-10-14 |
| SVF Endurance (Cayman) Ltd | 10 percent owner | 2025-10-10 | S-Sale | 6.0752 | 2025-10-14 |
| SVF Endurance (Cayman) Ltd | 10 percent owner | 2025-10-07 | S-Sale | 5.6029 | 2025-10-09 |
| SVF Endurance (Cayman) Ltd | 10 percent owner | 2025-10-08 | S-Sale | 6.0479 | 2025-10-09 |
| SVF Endurance (Cayman) Ltd | 10 percent owner | 2025-10-03 | S-Sale | 5.5553 | 2025-10-07 |
| SVF Endurance (Cayman) Ltd | 10 percent owner | 2025-10-06 | S-Sale | 5.6878 | 2025-10-07 |
| SATO VICKI L | director | 2025-10-01 | S-Sale | 5.8362 | 2025-10-02 |
| SATO VICKI L | director | 2025-09-02 | S-Sale | 4.9914 | 2025-09-03 |
| SATO VICKI L | director | 2025-08-01 | S-Sale | 4.9863 | 2025-08-04 |
| Eisner Mark | officer: EVP and Chief Medical Officer | 2025-07-15 | S-Sale | 5.4682 | 2025-07-17 |
| Eisner Mark | officer: EVP and Chief Medical Officer | 2025-07-17 | S-Sale | 5.4738 | 2025-07-17 |
| SATO VICKI L | director | 2025-07-01 | S-Sale | 5.1003 | 2025-07-02 |
| MORE ROBERT J | director | 2025-06-09 | J-Other | 0 | 2025-06-09 |
| MORE ROBERT J | director | 2025-06-09 | J-Other | 0 | 2025-06-09 |
| BISCHOFBERGER NORBERT W | director | 2025-06-06 | J-Other | 0 | 2025-06-06 |
| BISCHOFBERGER NORBERT W | director | 2025-06-06 | J-Other | 0 | 2025-06-06 |
| Sigal Charles Elliott | director | 2025-05-30 | A-Award | 0 | 2025-06-02 |
| Sigal Charles Elliott | director | 2025-05-30 | A-Award | 4.94 | 2025-06-02 |
| SATO VICKI L | director | 2025-05-30 | A-Award | 0 | 2025-06-02 |
| SATO VICKI L | director | 2025-05-30 | A-Award | 4.94 | 2025-06-02 |
| Ramasastry Saira | director | 2025-05-30 | A-Award | 0 | 2025-06-02 |
| Ramasastry Saira | director | 2025-05-30 | A-Award | 4.94 | 2025-06-02 |
| Napolitano Janet | director | 2025-05-30 | A-Award | 0 | 2025-06-02 |